Snopes Gives NYT ‘Mostly False’ Rating Over Article About Trump And Hydroxychloroquine

Win McNamee/Getty Images

William Davis Contributor
Font Size:

Snopes fact-checked a New York Times article that argued that President Donald Trump could stand to benefit financially from hydroxychloroquine being used to treat coronavirus patients, deeming the article “mostly false.”

The New York Times published an article Tuesday mentioning the president’s small financial stake Sanofi, a French  pharmaceutical company that produces the anti-malaria drug that has shown to be effective in treating the virus. Trump’s personal stake in the company is estimated to be as small as $99. The president’s net worth is estimated to be between 3 and $4 billion. (RELATED: FLASHBACK: Jan. 21: Fauci Says Coronavirus ‘Not A Major Threat’ To U.S.)

“Because Trump’s financial interest in Sanofi and other pharmaceutical companies is indirect and minor, and because hydroxychloroquine is an easily produced generic drug unlikely to drive profit, we rank the claim that his promotion of the drug could lead to potential financial benefits as ‘Mostly false,’” the left-leaning fact check outlet wrote. (RELATED: Why Trump’s Approval Ratings Are Currently High And How That Could Change)

The president has repeatedly touted the promise of hydroxychloroquine as a therapeutic for the virus and waived FDA regulations last month to allow the drug to be quickly approved for treatment. The drug has been rated as the “most effective” treatment for the coronavirus by thousands of physicians.